We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 2,698

Life Sciences: product regulation and liability in Italy
  • Avvocati Associati Franzosi Dal Negro Setti
  • Global, Italy
  • February 19 2018

A structured guide to product regulation and liability laws in Italy


Clinical trials in France
  • Reed Smith LLP
  • France, Global
  • February 19 2018

A structured guide to clinical trials in France


Life Sciences: product regulation and liability in France
  • Reed Smith LLP
  • France, Global
  • February 19 2018

A structured guide to product regulation and liability laws in France


Pharmacovigilance in France
  • Reed Smith LLP
  • France, Global
  • February 19 2018

A structured guide to Pharmacovigilance in France


Poor patent quality, biosimilars, third-party disputes, Brexit and more from our pharma and biotech event
  • IAM
  • Global
  • February 17 2018

Last week, life sciences patent professionals from around the world gathered at London’s Hallam Conference Centre for IAM’s second annual Pharma and


The competition law issues of the CRISPR patent pool
  • Bristows
  • USA, European Union, Global
  • February 16 2018

CRISPR-Cas9 is heralded as a revolutionary gene editing technology that is regularly hitting the headlines for both its scientific promise and


DowDuPont revealed as the surprise leader in global CRISPR patents; study points to potential trouble ahead
  • IAM
  • Global
  • February 13 2018

A new study of the global CRISPR patent landscape released today provides the most detailed insight yet into how entities are seeking to protect their


International Life Sciences Review: Issue 8
  • Morgan Lewis
  • USA, Netherlands, China, European Union, France, Global
  • February 6 2018

The European Commission has published the Draft Regulation amending Regulation (EC) No 8472000 as regards the definition of the concept 'similar


Why talk of a pharma patent deal-making surge in 2018 is premature
  • IAM
  • Global
  • February 2 2018

A flurry of pharmaceuticals transactions in January has led several observers to describe the past month as the best start to M&A in recent years, and


Life sciences: product regulation and liability in Switzerland
  • Bär & Karrer
  • Switzerland, Global
  • January 24 2018

A structured guide to product regulation and liability laws in Switzerland